NCT05620134 Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05574504 Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy Status WITHDRAWN Phase PHASE2
NCT05566574 A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05560035 The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery Status UNKNOWN Phase NA
NCT05557045 A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 Status RECRUITING Phase PHASE1
NCT05555342 A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm Status COMPLETED Phase EARLY_PHASE1
NCT05544240 Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT05525858 KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II Status RECRUITING Phase N/A
NCT05508464 Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial Status RECRUITING Phase NA
NCT05502315 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer Status RECRUITING Phase PHASE2
NCT05495295 First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours Status RECRUITING Phase PHASE1
NCT05491928 Treatment of Metastatic Cancer in Terminally Diagnosed Patients Status AVAILABLE Phase N/A
NCT05489237 First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors Status RECRUITING Phase PHASE1
NCT05475171 Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION) Status SUSPENDED Phase PHASE2
NCT05438342 An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis Status UNKNOWN Phase NA
NCT05422911 Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. Status NOT_YET_RECRUITING Phase PHASE2
NCT05408871 Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases Status TERMINATED Phase PHASE1
NCT05394675 A Study of DS-9606a in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05394103 Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2